Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ATRI Atrion	$459.92	$459.06	$274.98 ▼ $503.24	$809.46M	0.69	23,283 shs	N/A
KIDS OrthoPediatrics	$21.88 +1.8%	$21.41	$19.52 ▼ $35.99	$532.19M	1.08	197,861 shs	84,616 shs
NVRO Nevro	$5.85 +0.1%	$5.85	$3.17 ▼ $10.37	$224.32M	0.81	789,244 shs	753,602 shs
SILK Silk Road Medical	$27.49	$27.31	$6.08 ▼ $27.51	$1.12B	1.53	1.20 million shs	N/A

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ATRI Atrion	0.00%	0.00%	0.00%	0.00%	+1.66%
KIDS OrthoPediatrics	+0.51%	+4.32%	+6.49%	-14.25%	-25.31%
NVRO Nevro	0.00%	0.00%	0.00%	+0.02%	-30.57%
SILK Silk Road Medical	0.00%	0.00%	0.00%	0.00%	+1.66%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ATRI Atrion	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
KIDS OrthoPediatrics	4.2117 of 5 stars	3.4	2.0	0.0	3.9	2.2	3.3	0.6
NVRO Nevro	0.1782 of 5 stars	1.0	0.0	0.0	0.0	0.0	1.7	0.6
SILK Silk Road Medical	0.3996 of 5 stars	0.8	0.0	0.0	4.3	0.0	0.0	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ATRI Atrion	0.00	N/A	N/A	N/A
KIDS OrthoPediatrics	2.83	Moderate Buy	$35.83	63.81% Upside
NVRO Nevro	1.92	Reduce	$5.36	-8.29% Downside
SILK Silk Road Medical	1.50	Reduce	$27.50	0.04% Upside

Current Analyst Ratings Breakdown

Latest NVRO, KIDS, SILK, and ATRI Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/8/2025	KIDS OrthoPediatrics	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$40.00 ➝ $30.00
5/8/2025	KIDS OrthoPediatrics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$42.00 ➝ $42.00
4/11/2025	KIDS OrthoPediatrics	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$26.00 ➝ $24.00
4/9/2025	KIDS OrthoPediatrics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$42.00 ➝ $42.00
4/7/2025	KIDS OrthoPediatrics	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$37.00

(Data available from 7/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ATRI Atrion	$181.60M	4.46	$19.68 per share	23.37	$138.02 per share	3.33
KIDS OrthoPediatrics	$204.73M	2.60	N/A	N/A	$14.64 per share	1.49
NVRO Nevro	$408.52M	0.55	N/A	N/A	$8.10 per share	0.72
SILK Silk Road Medical	$177.13M	6.31	N/A	N/A	$3.88 per share	7.09

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ATRI Atrion	$19.41M	$10.64	43.23	∞	N/A	10.60%	7.75%	7.12%	N/A
KIDS OrthoPediatrics	-$37.82M	-$1.75	N/A	N/A	N/A	-19.15%	-7.03%	-5.45%	8/4/2025 (Estimated)
NVRO Nevro	-$92.21M	-$3.05	N/A	N/A	N/A	-16.54%	-23.52%	-10.83%	8/4/2025 (Estimated)
SILK Silk Road Medical	-$55.74M	-$1.37	N/A	N/A	N/A	-29.53%	-37.30%	-21.57%	N/A

Latest NVRO, KIDS, SILK, and ATRI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
5/7/2025	Q1 2025	KIDS OrthoPediatrics	-$0.26	-$0.39	-$0.13	-$0.46	$51.68 million	$52.41 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ATRI Atrion	$8.80	1.91%	N/A	82.71%	21 Years
KIDS OrthoPediatrics	N/A	N/A	N/A	N/A	N/A
NVRO Nevro	N/A	N/A	N/A	N/A	N/A
SILK Silk Road Medical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ATRI Atrion	N/A	9.18	3.06
KIDS OrthoPediatrics	0.21	6.19	2.99
NVRO Nevro	0.67	5.02	3.76
SILK Silk Road Medical	0.49	7.63	6.69

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ATRI Atrion	66.19%
KIDS OrthoPediatrics	69.05%
NVRO Nevro	95.52%
SILK Silk Road Medical	N/A

Insider Ownership

Company	Insider Ownership
ATRI Atrion	22.82%
KIDS OrthoPediatrics	31.80%
NVRO Nevro	3.20%
SILK Silk Road Medical	3.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ATRI Atrion	720	1.76 million	1.36 million	Not Optionable
KIDS OrthoPediatrics	200	24.29 million	16.56 million	Optionable
NVRO Nevro	1,090	38.37 million	36.27 million	Optionable
SILK Silk Road Medical	410	40.63 million	37.91 million	Optionable

NVRO, KIDS, SILK, and ATRI Headlines

Recent News About These Companies

Photos show where US and China have sent hospital ships

June 18, 2025 | msn.com

Three Andritz spunlace lines for Alear Silk Road

April 25, 2025 | innovationintextiles.comI

ANDRITZ To Supply Three Spunlace Lines To Alear Silk Road New Materials, China

April 25, 2025 | textileworld.comT

2,200-year-old grave in China contains 'Red Princess of the Silk Road' whose teeth were painted with a toxic substance

March 12, 2025 | msn.com

Xinjiang a front-runner in BRI medical cooperation

March 7, 2025 | chinadaily.com.cnC

Endologix Appoints Andrew Davis as Chief Commercial Officer

March 3, 2025 | businesswire.com

China’s Belt and Road Initiative: The art of exploiting threats and opportunities

February 21, 2025 | tehrantimes.comT

Boston Scientific ramped up headcount, real estate footprint in 2024

February 21, 2025 | bizjournals.com

Trump pardons Silk Road founder Ross Ulbricht for online drug scheme

January 23, 2025 | reuters.com

Trump pardons Ross Ulbricht, creator of online black market for illegal drugs

January 23, 2025 | msn.com

Trump pardons founder of Silk Road website

January 23, 2025 | msn.com

Silk Road founder Ross Ulbricht went to prison a libertarian hero. Trump just set him free.

January 22, 2025 | msn.com

Trump pardons online drug marketplace Silk Road founder, Austin native Ross Ulbricht

January 22, 2025 | msn.com

Who Is Ross Ulbricht? What To Know About ‘Silk Road’ Drug Marketplace Founder Pardoned By Trump.

January 22, 2025 | msn.com

Trump pardons Ross Ulbricht, founder of online drug market Silk Road

January 22, 2025 | msn.com

Trump Pardons Creator of Silk Road Drug Marketplace

January 22, 2025 | nytimes.com

Chinese, Pakistani firms sign $250m MoUs

January 19, 2025 | tribune.com.pkT

MoUs worth $250m signed with Chinese medical companies

January 19, 2025 | dawn.comD

Pakistani, Chinese companies ink $250mn MoUs to boost medical sector

January 18, 2025 | brecorder.comB

Pakistani, Chinese companies ink $250 million MoUs to boost medical sector

January 18, 2025 | business-standard.comB

New MarketBeat Followers Over Time

Media Sentiment Over Time

NVRO, KIDS, SILK, and ATRI Company Descriptions

Atrion NASDAQ:ATRI

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company's ophthalmic products consist of a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

OrthoPediatrics NASDAQ:KIDS

$21.88 +0.40 (+1.84%)

As of 03:55 PM Eastern

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Nevro NYSE:NVRO

$5.85 +0.01 (+0.10%)

Closing price 04/2/2025

Extended Trading

$5.85 0.00 (0.00%)

As of 04/2/2025 07:56 PM Eastern

Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems. It also offers Senza HFX iQ platform, that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system; and provides sacroiliac joint fusion devices under NevroV1, NevroFix, and NevroPro brands. In addition, the company offers surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California.

Silk Road Medical NASDAQ:SILK

Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time